| abstract |
Disclosed is a method for treating a subject's influenza virus infection, or a disease, disorder or mechanism associated therewith, comprising a therapeutically effective amount of a catechol of general formula (I) for said subject. Administering butane or a pharmaceutically acceptable salt thereof, wherein R 1 and R 2 each independently represent hydrogen, lower alkyl, lower acyl, alkylene, or —OR 1 and -OR 2 each independently represents an unsubstituted or substituted amino acid residue thereof or a pharmaceutically acceptable salt thereof, and R 3 , R 4 , R 5 , R 6 , R 10 , R 11 , R 12 and R 13 each independently represent hydrogen or lower alkyl, and R 7 , R 8 and R 9 each independently represent hydrogen, —OH, lower alkoxy, lower acyloxy, unsubstituted or Substituted amino acid residues or pharmaceutically acceptable salts thereof Or, any two adjacent groups can be alkylene engine oxy (alkyene dioxy), however, where, when one of R 7, R 8 and R 9 is represents hydrogen, -OR 1, -OR 2 and the other two of R 7 , R 8 and R 9 do not represent -OH at the same time. |